CDEK by Data4ThePeople

Sign in Sign up

← All organizations

DOV Pharmaceutical, Inc.

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 1, 2008

Acquired by Euthymics BioScience, Inc. → Ethismos on Jul 1, 2010

Timeline

1990s

Jun 1, 1995
DOV Pharmaceutical, Inc.— Founded

2010s

Jul 1, 2010
Euthymics BioScience, Inc.— Acquired By
Nov 1, 2017
Ethismos— Now

Drugs by trial phase (2 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

bicifadine

Phase 2 (1 own, 0 via acquisition)

amitifadine

Indications

Studied for

Recent trials (5)

NCT00659347Study directorPhase 2Mar 1, 2008
NCT00659347Lead sponsorPhase 2Mar 1, 2008
NCT00295724Lead sponsorPhase 3Oct 1, 2005
NCT00281645Lead sponsorPhase 3Dec 1, 2004
NCT00295711Lead sponsorPhase 3Sep 1, 2004

Details

Founded: Hackensack, NJ, US Jun 1, 1995
Last known activity: Mar 1, 2008